BIOVERATIV THERAPEUTICS INC

Organization

CAMBRIDGE, MA, US

Ticker Symbols

NASDAQ:BIVV

PHARMACEUTICAL PREPARATIONS
Business Address
225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Mailing Address
225 2ND AVENUE WALTHAM MA 02451
State Location
MA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Factor VIII chimeric and hybrid polypeptides, and methods of use th...
- Patent number 12,186,375
- Issue date Jan 7, 2025
- Bioverativ Therapeutics Inc.
- Jennifer A. Dumont
- G01 - MEASURING TESTING
Information Patent Grant
Methods for the purification of viral vectors
- Patent number 12,173,307
- Issue date Dec 24, 2024
- Bioverativ Therapeutics Inc.
- Mukesh Mayani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules and uses thereof
- Patent number 12,168,776
- Issue date Dec 17, 2024
- Bioverativ Therapeutics Inc.
- Alexey Seregin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating hemophilic arthropathy using chimeric clotting...
- Patent number 12,161,696
- Issue date Dec 10, 2024
- Bioverativ Therapeutics Inc.
- Jennifer Dumont
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
On-column viral inactivation methods
- Patent number 12,134,632
- Issue date Nov 5, 2024
- Bioverativ Therapeutics Inc.
- Glen Bolton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lyophilized factor IX formulations
- Patent number 12,128,092
- Issue date Oct 29, 2024
- Bioverativ Therapeutics Inc.
- Brian M. Thome
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating hemophilia A
- Patent number 12,030,925
- Issue date Jul 9, 2024
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized factor VIII gene
- Patent number 11,787,851
- Issue date Oct 17, 2023
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Optimized factor VIII genes
- Patent number 11,753,461
- Issue date Sep 12, 2023
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Assays to monitor bleeding disorders
- Patent number 11,747,351
- Issue date Sep 5, 2023
- Bioverativ Therapeutics Inc.
- Jurg Sommer
- G01 - MEASURING TESTING
Information Patent Grant
Recombinant factor VIII proteins
- Patent number 11,685,771
- Issue date Jun 27, 2023
- Bioverativ Therapeutics Inc.
- John Kulman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor IX polypeptide formulations
- Patent number 11,642,398
- Issue date May 9, 2023
- Bioverativ Therapeutics Inc.
- Mark Brader
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
On-column viral inactivation methods
- Patent number 11,578,098
- Issue date Feb 14, 2023
- Bioverativ Therapeutics Inc.
- Glen Bolton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,401,322
- Issue date Aug 2, 2022
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Device container
- Patent number 11,382,831
- Issue date Jul 12, 2022
- Bioverativ Therapeutics Inc.
- Christine P. Janson
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Grant
Chimeric factor VIII polypeptides and uses thereof
- Patent number 11,370,827
- Issue date Jun 28, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Blood factor monitoring assay and uses thereof
- Patent number 11,372,008
- Issue date Jun 28, 2022
- Bioverativ Therapeutics Inc.
- Jurg Sommer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of reducing immunogenicity against factor VIII in individua...
- Patent number 11,286,528
- Issue date Mar 29, 2022
- Bioverativ Therapeutics Inc.
- Haiyan Jiang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use...
- Patent number 11,266,720
- Issue date Mar 8, 2022
- Bioverativ Therapeutics Inc.
- Jennifer A. Dumont
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Procoagulant compounds
- Patent number 11,261,437
- Issue date Mar 1, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong Hong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of using FIX polypeptides
- Patent number 11,225,650
- Issue date Jan 18, 2022
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using FIX polypeptides
- Patent number 11,193,116
- Issue date Dec 7, 2021
- Bioverativ Therapeutics Inc.
- Glenn Pierce
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII chimeric proteins and uses thereof
- Patent number 11,192,936
- Issue date Dec 7, 2021
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,168,125
- Issue date Nov 9, 2021
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII complex with XTEN and von Willebrand Factor protein, an...
- Patent number 11,091,534
- Issue date Aug 17, 2021
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,084,866
- Issue date Aug 10, 2021
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Optimized factor IX gene
- Patent number 11,008,561
- Issue date May 18, 2021
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric clotting factors
- Patent number 10,968,442
- Issue date Apr 6, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purification of chimeric FVIII molecules
- Patent number 10,947,269
- Issue date Mar 16, 2021
- Bioverativ Therapeutics Inc.
- Lily Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processable single chain molecules and polypeptides made using same
- Patent number 10,927,362
- Issue date Feb 23, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING HEMOPHILIA A
- Publication number 20240400645
- Publication date Dec 5, 2024
- Bioverativ Therapeutics Inc.
- Ekta SETH CHHABRA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
- Publication number 20240358800
- Publication date Oct 31, 2024
- Bioverativ Therapeutics Inc.
- Tyler CARLAGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACIDS ENCODING FACTOR VIII POLYPEPTIDES WITH REDUCED IMMUNO...
- Publication number 20240350672
- Publication date Oct 24, 2024
- Bioverativ Therapeutics Inc.
- Tongyao LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED ITR SEQUENCES AND METHODS OF USE
- Publication number 20240350671
- Publication date Oct 24, 2024
- Bioverativ Therapeutics Inc.
- Ajay Maghodia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BACULOVIRUS EXPRESSION SYSTEM
- Publication number 20240294940
- Publication date Sep 5, 2024
- Bioverativ Therapeutics Inc.
- Tongyao Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
- Publication number 20240287158
- Publication date Aug 29, 2024
- Bioverativ Therapeutics Inc.
- Tyler CARLAGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF
- Publication number 20240212861
- Publication date Jun 27, 2024
- Bioverativ Therapeutics Inc.
- Haiyan Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED FACTOR VIII GENE
- Publication number 20240141019
- Publication date May 2, 2024
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTIMIZED FACTOR VIII GENES
- Publication number 20240124555
- Publication date Apr 18, 2024
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF
- Publication number 20240083975
- Publication date Mar 14, 2024
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMPK Activators and Methods of Use Thereof
- Publication number 20230338344
- Publication date Oct 26, 2023
- Bioverativ Therapeutics Inc.
- Pauline RIMMELÉ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ON-COLUMN VIRAL INACTIVATION METHODS
- Publication number 20230331774
- Publication date Oct 19, 2023
- Bioverativ Therapeutics Inc.
- Glen BOLTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT FACTOR VIII PROTEINS
- Publication number 20230322901
- Publication date Oct 12, 2023
- Bioverativ Therapeutics Inc.
- John KULMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20230322900
- Publication date Oct 12, 2023
- Bioverativ Therapeutics Inc.
- Volker Schellenberger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR IX POLYPEPTIDE FORMULATIONS
- Publication number 20230310560
- Publication date Oct 5, 2023
- Bioverativ Therapeutics Inc.
- Mark BRADER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES BINDING TO COAGULATION FACTOR IX AND COAGULAT...
- Publication number 20230192896
- Publication date Jun 22, 2023
- Bioverativ Therapeutics Inc.
- Robert T. PETERS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES
- Publication number 20230091932
- Publication date Mar 23, 2023
- Bioverativ Therapeutics Inc.
- Ajay Maghodia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED FACTOR VIII GENES
- Publication number 20230084036
- Publication date Mar 16, 2023
- Bioverativ Therapeutics Inc.
- Ajay Maghodia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
- Publication number 20230023927
- Publication date Jan 26, 2023
- Bioverativ Therapeutics Inc.
- Robert T. PETERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20230019286
- Publication date Jan 19, 2023
- Bioverativ Therapeutics Inc.
- Volker SCHELLENBERGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF
- Publication number 20230011438
- Publication date Jan 12, 2023
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUA...
- Publication number 20230002828
- Publication date Jan 5, 2023
- Bioverativ Therapeutics Inc.
- Haiyan Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BLOOD FACTOR MONITORING ASSAY AND USES THEREOF
- Publication number 20220412996
- Publication date Dec 29, 2022
- Bioverativ Therapeutics Inc.
- Jurg SOMMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BACULOVIRUS EXPRESSION SYSTEM
- Publication number 20220356490
- Publication date Nov 10, 2022
- Bioverativ Therapeutics Inc.
- Tongyao Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DEVICE CONTAINER
- Publication number 20220296469
- Publication date Sep 22, 2022
- Bioverativ Therapeutics Inc.
- Christine P. JANSON
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
- Publication number 20220275057
- Publication date Sep 1, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE...
- Publication number 20220265780
- Publication date Aug 25, 2022
- Bioverativ Therapeutics Inc.
- Jennifer A. DUMONT
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
PROCOAGULANT COMPOUNDS
- Publication number 20220243189
- Publication date Aug 4, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong HONG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED ITR SEQUENCES AND METHODS OF USE
- Publication number 20220243201
- Publication date Aug 4, 2022
- Bioverativ Therapeutics Inc.
- Ajay Maghodia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT FACTOR VIII-FC FOR TREATING HEMOPHILIA AND LOW BONE MIN...
- Publication number 20220233650
- Publication date Jul 28, 2022
- Bioverativ Therapeutics Inc.
- Susu DUAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
97844973 - ALTUVIIIO
- Serial number 97844973
- Registration number 7352626
- Filing date Mar 17, 2023
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97403774 - ALTUVOCT
- Serial number 97403774
- Filing date May 10, 2022
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97062260 - ALTUVIO
- Serial number 97062260
- Filing date Oct 6, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90850288 - 8
- Serial number 90850288
- Registration number 6646404
- Filing date Jul 27, 2021
- BIOVERATIV THERAPEUTICS INC.
- 44 - Medical services
Information Trademark
90626528 - ALTUVIIIO
- Serial number 90626528
- Registration number 7151486
- Filing date Apr 6, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90596383 - FACZEED
- Serial number 90596383
- Filing date Mar 23, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90593749 - ELTULEVY
- Serial number 90593749
- Filing date Mar 22, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90593766 - ALTUVIIO
- Serial number 90593766
- Filing date Mar 22, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90593775 - EXYMZUS
- Serial number 90593775
- Filing date Mar 22, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90593754 - ELTULVY
- Serial number 90593754
- Filing date Mar 22, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90593758 - BIVTEFA
- Serial number 90593758
- Filing date Mar 22, 2021
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90275329 - REEVHAEMA
- Serial number 90275329
- Filing date Oct 23, 2020
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90275335 - NAURMYZA
- Serial number 90275335
- Filing date Oct 23, 2020
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90275339 - AURMOLIZE
- Serial number 90275339
- Filing date Oct 23, 2020
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88573199
- Serial number 88573199
- Registration number 6725270
- Filing date Aug 9, 2019
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88255416 - GIVJOVA
- Serial number 88255416
- Filing date Jan 9, 2019
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88255430 - ENJAYMO
- Serial number 88255430
- Registration number 6713660
- Filing date Jan 9, 2019
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88100628 - CIBEMTOR
- Serial number 88100628
- Filing date Aug 31, 2018
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88100618 - SIMTELCIS
- Serial number 88100618
- Filing date Aug 31, 2018
- BIOVERATIV THERAPEUTICS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87870243 - RARE VALUE IT'S IN OUR BLOOD
- Serial number 87870243
- Filing date Apr 10, 2018
- BIOVERATIV THERAPEUTICS INC.
- 35 - Advertising
Information Trademark
87870220 - RARE VALUE
- Serial number 87870220
- Filing date Apr 10, 2018
- BIOVERATIV THERAPEUTICS INC.
- 35 - Advertising
Information Trademark
87870235 - RARE VALUE IT'S IN OUR BLOOD
- Serial number 87870235
- Filing date Apr 10, 2018
- BIOVERATIV THERAPEUTICS INC.
- 35 - Advertising
Information Trademark
87870231 - RARE VALUE
- Serial number 87870231
- Filing date Apr 10, 2018
- BIOVERATIV THERAPEUTICS INC.
- 35 - Advertising
Information Trademark
87870239 - RARE VALUE
- Serial number 87870239
- Filing date Apr 10, 2018
- BIOVERATIV THERAPEUTICS INC.
- 35 - Advertising
Information Trademark
87711985 - SCIENCE MATTERS. BECAUSE PATIENTS MATTER.
- Serial number 87711985
- Filing date Dec 7, 2017
- BIOVERATIV THERAPEUTICS INC.
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
87704427 - BE HEALTHY TODAY FOR TOMORROW
- Serial number 87704427
- Filing date Dec 1, 2017
- BIOVERATIV THERAPEUTICS INC.
- 41 - Education
Information Trademark
87666569 - BE HEALTHY FOR THE FUTURE
- Serial number 87666569
- Filing date Oct 31, 2017
- BIOVERATIV THERAPEUTICS INC.
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
87666559 - HUMANPHILIA
- Serial number 87666559
- Filing date Oct 31, 2017
- BIOVERATIV THERAPEUTICS INC.
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
87626783 - HEMOPHILIA TOGETHER BY BIOVERATIV
- Serial number 87626783
- Filing date Sep 28, 2017
- BIOVERATIV THERAPEUTICS INC.
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
87610560 - HEMOPHILIA TOGETHER
- Serial number 87610560
- Filing date Sep 15, 2017
- BIOVERATIV THERAPEUTICS INC.
- 16 - Paper, cardboard and goods made from these materials, not included in other classes

BIOVERATIV THERAPEUTICS INC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Factor VIII chimeric and hybrid polypeptides, and methods of use th...

Methods for the purification of viral vectors

Nucleic acid molecules and uses thereof

Methods of treating hemophilic arthropathy using chimeric clotting...

On-column viral inactivation methods

Lyophilized factor IX formulations

Methods of treating hemophilia A

Optimized factor VIII gene

Optimized factor VIII genes

Assays to monitor bleeding disorders

Recombinant factor VIII proteins

Factor IX polypeptide formulations

On-column viral inactivation methods

Immunoglobulin chimeric monomer-dimer hybrids

Device container

Chimeric factor VIII polypeptides and uses thereof

Blood factor monitoring assay and uses thereof

Methods of reducing immunogenicity against factor VIII in individua...

Factor VIII-FC chimeric and hybrid polypeptides, and methods of use...

Procoagulant compounds

Methods of using FIX polypeptides

Methods of using FIX polypeptides

Factor VIII chimeric proteins and uses thereof

Immunoglobulin chimeric monomer-dimer hybrids

Factor VIII complex with XTEN and von Willebrand Factor protein, an...

Immunoglobulin chimeric monomer-dimer hybrids

Optimized factor IX gene

Chimeric clotting factors

Purification of chimeric FVIII molecules

Processable single chain molecules and polypeptides made using same

Patents Applicationslast 30 patents

METHODS OF TREATING HEMOPHILIA A

FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

NUCLEIC ACIDS ENCODING FACTOR VIII POLYPEPTIDES WITH REDUCED IMMUNO...

ENGINEERED ITR SEQUENCES AND METHODS OF USE

BACULOVIRUS EXPRESSION SYSTEM

FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF

OPTIMIZED FACTOR VIII GENE

OPTIMIZED FACTOR VIII GENES

THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF

AMPK Activators and Methods of Use Thereof

ON-COLUMN VIRAL INACTIVATION METHODS

RECOMBINANT FACTOR VIII PROTEINS

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

FACTOR IX POLYPEPTIDE FORMULATIONS

BISPECIFIC ANTIBODIES BINDING TO COAGULATION FACTOR IX AND COAGULAT...

CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES

OPTIMIZED FACTOR VIII GENES

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF

METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUA...

BLOOD FACTOR MONITORING ASSAY AND USES THEREOF

BACULOVIRUS EXPRESSION SYSTEM

DEVICE CONTAINER

FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE...

PROCOAGULANT COMPOUNDS

ENGINEERED ITR SEQUENCES AND METHODS OF USE

RECOMBINANT FACTOR VIII-FC FOR TREATING HEMOPHILIA AND LOW BONE MIN...

Trademarklast 30 trademarks

97844973 - ALTUVIIIO

97403774 - ALTUVOCT

97062260 - ALTUVIO

90850288 - 8

90626528 - ALTUVIIIO

90596383 - FACZEED

90593749 - ELTULEVY

90593766 - ALTUVIIO

90593775 - EXYMZUS

90593754 - ELTULVY